| Literature DB >> 18588933 |
Daniela M Resende1, Bráulia C Caetano, Míriam S Dutra, Marcus L O Penido, Christiane F Abrantes, Rodrigo M Verly, Jarbas M Resende, Dorila Piló-Veloso, Simone Aparecida Rezende, Oscar Bruna-Romero, Ana Paula Fernandes, Ricardo T Gazzinelli.
Abstract
A2 was identified as an amastigote virulence factor of Leishmania (Leishmania) donovani and as a candidate antigen for vaccine development against visceral leishmaniasis. Here, predicted hydrophilic, class I and II MHC-binding synthetic peptides were used to define epitopes recognized by A2-specific antibodies, CD8+ T and CD4+ T cells, respectively. Immunization of BALB/c mice with adenovirus expressing A2 (AdA2) resulted in low antibody response, contrasting with high levels of IFN-gamma producing CD4+ T and CD8+ T cells specific for A2. Further, A2-specific CD8+ T cells from immunized mice were capable of lysing sensitized target cells in vivo. Finally, we demonstrated an association of A2-specific T cell responses and reduced parasitism in both liver and spleen from mice immunized with AdA2 and challenged with L. (L.) chagasi.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18588933 DOI: 10.1016/j.vaccine.2008.05.091
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641